Please login to the form below

Not currently logged in
Email:
Password:

Aprecia

This page shows the latest Aprecia news and features for those working in and with pharma, biotech and healthcare.

3D printed epilepsy drug launched in the US

3D printed epilepsy drug launched in the US

3D printed epilepsy drug launched in the US. Aprecia’ s Spritam is now available as a prescription drug. ... Aprecia Pharmaceutical's Spritam was approved by the FDA in August last year, with industry experts hailing it as the catalyst for a new era in

Latest news

  • Printable pharma Printable pharma

    Spritam is designed to fill a need for patients who struggle with their current medication experience,” commented Don Wetherhold, Aprecia's chief executive. “ ... This is the first in a line of central nervous system products Aprecia plans to

  • FDA approves world’s first 3D printed drug FDA approves world’s first 3D printed drug

    FDA approves world’ s first 3D printed drug. Aprecia’ s epilepsy treatment Spritam seen as the future of drug manufacturing. ... experience. "This is the first in a line of central nervous system products Aprecia plans to introduce as part of our

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics